证券时报·数据宝统计，两融数据来看，该股最新（12月19日）两融余额为4.72亿元，其中，融资余额 4.72亿元，较前一个交易日增加3588.52万元，环比增长8.23%，近3日累计减少46.17万元，环比下降 0.10%。 | 日期 | 当日涨跌幅（%） | 换手率（%） | 主力资金净流入（万元） | | --- | --- | --- | --- | | 2025.12.19 | 9.96 | 30.98 | -15295.99 | | 2025.12.18 | 10.07 | 7.91 | 21068.31 | | 2025.12.17 | -3.30 | 7.39 | -5823.65 | | 2025.12.16 | -2.24 | 8.42 | -2390.97 | | 2025.12.15 | 5.31 | 13.34 | 1116.44 | | 2025.12.12 | 0.59 | 7.44 | 1099.88 | | 2025.12.11 | 1.81 | 4.52 | 2338.25 | | 2025.12.10 | 0.46 | 2.74 | -2347.52 | | 2025.12 ...

Group 1 - The core viewpoint of the news is that Baomo Co., Ltd. has shown significant financial activity, with a notable increase in revenue and net profit, indicating strong business performance [2][3] - As of December 19, Baomo's stock price increased by 1.00%, with a trading volume of 71.84 million yuan, and a net financing outflow of 2.23 million yuan [1] - The company's financing balance reached 310 million yuan, accounting for 8.36% of its market capitalization, which is above the 90th percentile of the past year [1] Group 2 - For the period from January to September 2025, Baomo achieved an operating income of 453 million yuan, representing a year-on-year growth of 17.29%, and a net profit attributable to shareholders of 37.87 million yuan, up 62.06% year-on-year [2] - The company has distributed a total of 131 million yuan in dividends since its A-share listing, with 12.24 million yuan distributed in the last three years [3] - As of December 10, the number of shareholders decreased by 5.63% to 36,700, while the average circulating shares per person increased by 5.97% to 16,668 shares [2]

融券方面，新宙邦12月19日融券偿还3500.00股，融券卖出5.04万股，按当日收盘价计算，卖出金额 248.57万元；融券余量12.69万股，融券余额625.77万元，超过近一年50%分位水平，处于较高位。 资料显示，深圳新宙邦科技股份有限公司位于广东省深圳市坪山区昌业路新宙邦科技大厦，成立日期 2002年2月19日，上市日期2010年1月8日，公司主营业务涉及新型电子化学品及功能材料的研发、生 产、销售和服务。主营业务收入构成为：电池化学品66.43%，有机氟化学品17.03%，电子信息化学品 16.03%，其他(补充)0.50%。 12月19日，新宙邦涨2.84%，成交额9.92亿元。两融数据显示，当日新宙邦获融资买入额7571.92万元， 融资偿还8426.95万元，融资净买入-855.03万元。截至12月19日，新宙邦融资融券余额合计10.34亿元。 融资方面，新宙邦当日融资买入7571.92万元。当前融资余额10.28亿元，占流通市值的2.79%，融资余 额超过近一年90%分位水平，处于高位。 机构持仓方面，截止2025年9月30日，新宙邦十大流通股东中，易方达创业板ETF（159915）位居第 ...

Group 1 - On December 19, Yongtai Technology's stock rose by 4.49%, with a trading volume of 1.548 billion yuan [1] - The financing data shows that on the same day, Yongtai Technology had a financing purchase amount of 281 million yuan, with a net financing purchase of 125 million yuan [1] - As of December 19, the total balance of margin trading for Yongtai Technology was 1.345 billion yuan, with the financing balance accounting for 6.34% of the circulating market value, indicating a high level compared to the past year [1] Group 2 - As of September 30, Yongtai Technology had 107,700 shareholders, an increase of 7.56% from the previous period [2] - For the period from January to September 2025, Yongtai Technology achieved an operating income of 4.028 billion yuan, a year-on-year increase of 20.65%, and a net profit attributable to shareholders of 32.55 million yuan, up 136.23% year-on-year [2] - The company has distributed a total of 521 million yuan in dividends since its A-share listing, with 87.66 million yuan distributed in the last three years [2]

12月19日，硅宝科技涨1.62%，成交额2.53亿元。两融数据显示，当日硅宝科技获融资买入额3405.86万 元，融资偿还3640.72万元，融资净买入-234.86万元。截至12月19日，硅宝科技融资融券余额合计4.35 亿元。 融资方面，硅宝科技当日融资买入3405.86万元。当前融资余额4.35亿元，占流通市值的5.36%，融资余 额超过近一年80%分位水平，处于高位。 截至9月30日，硅宝科技股东户数3.73万，较上期减少2.84%；人均流通股9037股，较上期增加2.92%。 2025年1月-9月，硅宝科技实现营业收入26.51亿元，同比增长24.30%；归母净利润2.29亿元，同比增长 44.63%。 分红方面，硅宝科技A股上市后累计派现8.50亿元。近三年，累计派现3.53亿元。 机构持仓方面，截止2025年9月30日，硅宝科技十大流通股东中，香港中央结算有限公司位居第九大流 通股东，持股254.58万股，相比上期减少58.95万股。 责任编辑：小浪快报 融券方面，硅宝科技12月19日融券偿还0.00股，融券卖出0.00股，按当日收盘价计算，卖出金额0.00 元；融券余量1.49万股，融券余额 ...

财经频道更多独家策划、专家专栏，免费查阅>> 格隆汇12月22日丨世名科技(300522.SZ)在投资者互动平台表示，公司电子级碳氢树脂产品已向部分下 游客户送样与小批量供应，目前客户验证工作正有序开展中。 责任编辑：栎树 ...

南财智讯12月22日电，联化科技在投资者关系活动中表示，公司目前暂无以二级市场融资为核心的资本 运作计划。2025年前三季度经营活动产生的现金流量净额约9亿元，自有资金足以支撑当前资本开支。 近期投资重点集中于临海基地与马来西亚基地建设，未来将根据战略项目需要及市场环境审慎评估是否 启动新的融资安排。 ...

Group 1: Agricultural Protection Business - The agricultural protection business currently accounts for a significant portion of the company's revenue, with plans for future development focusing on maintaining steady growth in this concentrated industry [1] - The company has established long-term strategic partnerships with multiple international agricultural companies, covering all stages of the product lifecycle [1] - The company has production bases across China and an overseas base in the UK, with plans to establish Malaysia as a second overseas base to enhance supply chain differentiation [1] Group 2: Pharmaceutical Business Development - The pharmaceutical business is rapidly developing, with a focus on attracting new strategic and high-viscosity clients [2] - The company has formed stable commercial relationships with several high-quality domestic and international clients, expanding its business cooperation scope [2] - Future growth in the pharmaceutical sector is expected as the company continues to promote products under patent protection and enhance its technical capabilities [2] Group 3: Research and Development Directions - The company is expanding its R&D efforts from traditional small molecule drugs to include amino acids, peptides, and other advanced drug delivery systems [3] - The team is focused on accelerating the transition of early clinical projects for clients, providing diverse linker synthesis services for ADC/PROTAC drugs [3] - These new directions are anticipated to broaden the company's CDMO service offerings and enable the acquisition of more projects [3] Group 4: CDMO Capabilities and Client Relationships - The company emphasizes enhancing its technical innovation, safety standards, production management, and quality assurance systems to meet client needs [4] - A strong intellectual property confidentiality system and a commitment to integrity have earned the company recognition from leading global agricultural and pharmaceutical clients [4] - The selection of suppliers by international clients is based on comprehensive evaluations of technology, regulations, environmental standards, and quality, leading to stable and long-term partnerships [5] Group 5: Capital Operations and Financial Outlook - Currently, the company has no plans for capital operations focused on secondary market financing, with recent capital expenditures directed towards the construction of coastal and Malaysian bases [5] - The net cash flow from operating activities for the first three quarters of 2025 was approximately 9 billion, sufficient to support planned capital expenditures [5] - Future financing plans will be evaluated based on strategic investment needs and market conditions [5] Group 6: New Energy Business - The company primarily focuses on the sales of lithium hexafluorophosphate and electrolyte products, with ongoing technical improvements in the lithium hexafluorophosphate project [5] - Revenue from the new energy business is expected to break through in 2025, with plans to deepen market penetration and optimize the supply chain [5]

南财智讯12月21日电，神剑股份公告，公司股票价格于2025年12月18日、19日连续2个交易日收盘价格 涨幅偏离值累计超过20%。根据深圳证券交易所相关规定，属于股票交易异常波动的情况。经自查及向 控股股东、实际控制人书面问询确认，公司前期披露的信息不存在需要更正、补充之处；近期未发现其 他公共媒体报道了可能或已经对公司股票交易价格产生较大影响的未公开重大信息；目前经营情况及内 外部经营环境未发生重大变化；在股票交易异常波动期间，控股股东及实际控制人不存在关于公司的应 披露而未披露的重大事项或处于筹划阶段的重大事项，亦不存在买卖公司股票的情形；公司不存在违反 信息公平披露的情形。公司董事会确认，除已公开披露的信息外，目前没有任何应予以披露而未披露的 事项，也未获悉任何对公司股票及其衍生品种交易价格产生较大影响的信息。 ...

Key Points - Zoran Co., Ltd. and its actual controller received a notice of case filing [1] - Huati Technology clarified that it is not involved in commercial aerospace-related businesses [1] Investment Projects - Qingdao Port plans to invest CNY 9.097 billion in the construction of the first phase of the Dongjiakou Container Terminal [1] - Qingdao Port also plans to invest CNY 6.615 billion in the construction of the Dongjiakou General Terminal [1] - Jinggong Technology's subsidiary plans to invest in the construction of an intelligent manufacturing base for advanced composite materials [1] Contract Awards - Shandong Road and Bridge's subsidiary is expected to win a construction project for the Weifang to Yiyuan Expressway with a bid price of CNY 3.4 billion [1] - Tianjin Port won a procurement project for gantry cranes worth CNY 89.7655 million [1] - Tianjin Port also won a procurement project for door machines worth CNY 185 million [1] - Dayu Water-saving is expected to win a drainage remediation project in Hainan Province's Qionghai East Sea Village [1] Equity Transfers - Sanyuan Co., Ltd. plans to transfer 10% of Sanyuan Dehong's equity to Nanjiao Farm for CNY 26.8515 million [1] - Huayuan Holdings' subsidiary plans to acquire 51% of Warm Core Technology [1] - Qiyiyi plans to acquire 52.4596% of Fangzhou Technology and provide additional capital [1] Share Buybacks - Baiao Chemical has repurchased a total of 11.3876 million shares [2] Shareholding Changes - Sanwei Communication's chairman and general manager Li Yuelun plans to reduce his holdings by up to 1.4906% [2] - Aikedi's Hong Kong Lintuo plans to reduce its holdings by up to 2.9882% [2] Other Financial Activities - Chongqing Steel plans to raise no more than CNY 1 billion through a private placement to Huabao Investment [2] - Bolivi plans to raise no more than CNY 650 million through a private placement [2] - Jingu Co., Ltd. received a notification for the Avatar low-carbon wheel project [2]